Novel motif:1
From FANTOM5_SSTAR
name: | motif1_TCGNAG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071460 | cellular response to cell-matrix adhesion | 2.515949e-10 |
GO:0010994 | free ubiquitin chain polymerization | 8.271057e-9 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.905711e-8 |
GO:0006379 | mRNA cleavage | 3.770924e-8 |
GO:0034470 | ncRNA processing | 1.021054e-7 |
GO:0040040 | thermosensory behavior | 1.534554e-7 |
GO:0006268 | DNA unwinding involved in replication | 1.858830e-7 |
GO:2000002 | negative regulation of DNA damage checkpoint | 1.970207e-7 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 1.970207e-7 |
GO:0021551 | central nervous system morphogenesis | 1.970207e-7 |
GO:0021588 | cerebellum formation | 1.970207e-7 |
GO:0021562 | vestibulocochlear nerve development | 2.511725e-7 |
GO:0097039 | protein linear polyubiquitination | 3.134306e-7 |
GO:0006853 | carnitine shuttle | 4.342535e-7 |
GO:0051549 | positive regulation of keratinocyte migration | 5.450166e-7 |
GO:0016233 | telomere capping | 6.206359e-7 |
GO:0051488 | activation of anaphase-promoting complex activity | 6.314233e-7 |
GO:0019087 | transformation of host cell by virus | 9.882323e-7 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.411093e-6 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 3.231447e-6 |
GO:0006406 | mRNA export from nucleus | 4.674314e-6 |
GO:0021604 | cranial nerve structural organization | 4.944376e-6 |
GO:0006353 | transcription termination, DNA-dependent | 5.453594e-6 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 7.268597e-6 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 9.352441e-6 |
GO:0090103 | cochlea morphogenesis | 9.893706e-6 |
GO:0030574 | collagen catabolic process | 1.018333e-5 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.057255e-5 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.321742e-5 |
GO:0060669 | embryonic placenta morphogenesis | 1.346355e-5 |
GO:0048561 | establishment of organ orientation | 1.388524e-5 |
GO:0046755 | non-lytic virus budding | 1.405845e-5 |
GO:0021602 | cranial nerve morphogenesis | 1.428249e-5 |
GO:0015696 | ammonium transport | 1.433112e-5 |
GO:0048102 | autophagic cell death | 1.539656e-5 |
GO:0090342 | regulation of cell aging | 1.782236e-5 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1.857630e-5 |
GO:0010498 | proteasomal protein catabolic process | 1.942331e-5 |
GO:0023035 | CD40 signaling pathway | 2.024181e-5 |
GO:0048702 | embryonic neurocranium morphogenesis | 2.306710e-5 |
GO:0051932 | synaptic transmission, GABAergic | 2.953703e-5 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 3.151521e-5 |
GO:0008033 | tRNA processing | 3.300296e-5 |
GO:0090224 | regulation of spindle organization | 3.916922e-5 |
GO:0021603 | cranial nerve formation | 4.153465e-5 |
GO:0006544 | glycine metabolic process | 4.342563e-5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 4.962461e-5 |
GO:2000774 | positive regulation of cellular senescence | 5.017668e-5 |
GO:0035986 | senescence-associated heterochromatin focus formation | 5.017668e-5 |
GO:2000772 | regulation of cellular senescence | 5.169851e-5 |
GO:2000597 | positive regulation of optic nerve formation | 5.873194e-5 |
GO:0061360 | optic chiasma development | 5.873194e-5 |
GO:0021633 | optic nerve structural organization | 5.873194e-5 |
GO:0035799 | ureter maturation | 5.873194e-5 |
GO:0021650 | vestibulocochlear nerve formation | 5.873194e-5 |
GO:0001823 | mesonephros development | 7.830568e-5 |
GO:0042254 | ribosome biogenesis | 8.193139e-5 |
GO:0032365 | intracellular lipid transport | 8.561012e-5 |
GO:0006298 | mismatch repair | 9.214029e-5 |
GO:0031860 | telomeric 3' overhang formation | 9.480062e-5 |
GO:0031081 | nuclear pore distribution | 9.480062e-5 |
GO:0090192 | regulation of glomerulus development | 1.002988e-4 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 1.072150e-4 |
GO:0009589 | detection of UV | 1.072150e-4 |
GO:0090193 | positive regulation of glomerulus development | 1.091276e-4 |
GO:0001302 | replicative cell aging | 1.097757e-4 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.216964e-4 |
GO:0021592 | fourth ventricle development | 1.226802e-4 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 1.316809e-4 |
GO:0060606 | tube closure | 1.329754e-4 |
GO:0035928 | rRNA import into mitochondrion | 1.339438e-4 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.340785e-4 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.462909e-4 |
GO:0001843 | neural tube closure | 1.476223e-4 |
GO:0044243 | multicellular organismal catabolic process | 1.546206e-4 |
GO:0001510 | RNA methylation | 1.592464e-4 |
GO:0072178 | nephric duct morphogenesis | 1.653776e-4 |
GO:0070979 | protein K11-linked ubiquitination | 1.697155e-4 |
GO:0006290 | pyrimidine dimer repair | 1.737908e-4 |
GO:0014020 | primary neural tube formation | 1.814523e-4 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 1.832742e-4 |
GO:0006405 | RNA export from nucleus | 1.969051e-4 |
GO:0009440 | cyanate catabolic process | 1.989144e-4 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 2.085369e-4 |
GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.086190e-4 |
GO:0006364 | rRNA processing | 2.091161e-4 |
GO:0034660 | ncRNA metabolic process | 2.098342e-4 |
GO:0009637 | response to blue light | 2.125631e-4 |
GO:0006285 | base-excision repair, AP site formation | 2.573737e-4 |
GO:0009650 | UV protection | 2.670660e-4 |
GO:0030513 | positive regulation of BMP signaling pathway | 2.721034e-4 |
GO:0048532 | anatomical structure arrangement | 2.750080e-4 |
GO:0031627 | telomeric loop formation | 2.819905e-4 |
GO:0030150 | protein import into mitochondrial matrix | 2.819905e-4 |
GO:0071585 | detoxification of cadmium ion | 2.941256e-4 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 3.047904e-4 |
GO:0051029 | rRNA transport | 3.167503e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 3.209527e-4 |
GO:0035566 | regulation of metanephros size | 3.248419e-4 |
GO:0072176 | nephric duct development | 3.274949e-4 |
GO:0007501 | mesodermal cell fate specification | 3.292783e-4 |
GO:0060976 | coronary vasculature development | 3.385720e-4 |
GO:0032392 | DNA geometric change | 3.655228e-4 |
GO:0009235 | cobalamin metabolic process | 3.712193e-4 |
GO:0033233 | regulation of protein sumoylation | 3.725002e-4 |
GO:0010225 | response to UV-C | 3.868642e-4 |
GO:0006398 | histone mRNA 3'-end processing | 3.892183e-4 |
GO:0021666 | rhombomere 5 formation | 4.355341e-4 |
GO:0021660 | rhombomere 3 formation | 4.355341e-4 |
GO:0072177 | mesonephric duct development | 4.355634e-4 |
GO:0030433 | ER-associated protein catabolic process | 4.491393e-4 |
GO:0001522 | pseudouridine synthesis | 4.555449e-4 |
GO:0034389 | lipid particle organization | 4.632934e-4 |
GO:0055024 | regulation of cardiac muscle tissue development | 4.764888e-4 |
GO:0072171 | mesonephric tubule morphogenesis | 4.856067e-4 |
GO:0033683 | nucleotide-excision repair, DNA incision | 4.901193e-4 |
GO:0000154 | rRNA modification | 4.974353e-4 |
GO:0031507 | heterochromatin formation | 5.014754e-4 |
GO:0016569 | covalent chromatin modification | 5.029655e-4 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 5.069740e-4 |
GO:0021771 | lateral geniculate nucleus development | 5.421535e-4 |
GO:0016570 | histone modification | 5.581453e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 5.676588e-4 |
GO:0060712 | spongiotrophoblast layer development | 6.158736e-4 |
GO:0070734 | histone H3-K27 methylation | 6.244446e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 6.354359e-4 |
GO:0060708 | spongiotrophoblast differentiation | 6.586479e-4 |
GO:0060242 | contact inhibition | 6.649106e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 7.017052e-4 |
GO:0045007 | depurination | 7.196075e-4 |
GO:0060236 | regulation of mitotic spindle organization | 7.323798e-4 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 7.524317e-4 |
GO:0032205 | negative regulation of telomere maintenance | 7.587953e-4 |
GO:0097029 | mature dendritic cell differentiation | 7.620489e-4 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 7.643188e-4 |
GO:0055021 | regulation of cardiac muscle tissue growth | 7.678393e-4 |
GO:0010923 | negative regulation of phosphatase activity | 7.889462e-4 |
GO:0031915 | positive regulation of synaptic plasticity | 8.609862e-4 |
GO:0006284 | base-excision repair | 8.734585e-4 |
GO:0022617 | extracellular matrix disassembly | 9.114523e-4 |
GO:0015695 | organic cation transport | 9.425935e-4 |
GO:0042026 | protein refolding | 9.697664e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 9.770821e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.037949e-3 |
GO:0035404 | histone-serine phosphorylation | 1.057752e-3 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 1.058921e-3 |
GO:0050685 | positive regulation of mRNA processing | 1.070386e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 1.078722e-3 |
GO:0021612 | facial nerve structural organization | 1.080035e-3 |
GO:0016072 | rRNA metabolic process | 1.096278e-3 |
GO:0006476 | protein deacetylation | 1.109808e-3 |
GO:0019532 | oxalate transport | 1.145267e-3 |
GO:0032682 | negative regulation of chemokine production | 1.152848e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.154618e-3 |
GO:0034633 | retinol transport | 1.158977e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 1.158977e-3 |
GO:0072091 | regulation of stem cell proliferation | 1.198634e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 1.287130e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.295249e-3 |
GO:0034351 | negative regulation of glial cell apoptosis | 1.309435e-3 |
GO:0090343 | positive regulation of cell aging | 1.335684e-3 |
GO:0060707 | trophoblast giant cell differentiation | 1.335684e-3 |
GO:0018022 | peptidyl-lysine methylation | 1.358558e-3 |
GO:0017121 | phospholipid scrambling | 1.380366e-3 |
GO:0090275 | negative regulation of somatostatin secretion | 1.407652e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.425290e-3 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 1.445765e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 1.445765e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.469564e-3 |
GO:0032984 | macromolecular complex disassembly | 1.508362e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 1.512960e-3 |
GO:0019348 | dolichol metabolic process | 1.512960e-3 |
GO:0043241 | protein complex disassembly | 1.519638e-3 |
GO:0030488 | tRNA methylation | 1.556328e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.603943e-3 |
GO:0043249 | erythrocyte maturation | 1.603943e-3 |
GO:0008272 | sulfate transport | 1.619287e-3 |
GO:0010172 | embryonic body morphogenesis | 1.622282e-3 |
GO:0010912 | positive regulation of isomerase activity | 1.622898e-3 |
GO:0032508 | DNA duplex unwinding | 1.652335e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 1.698326e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 1.699270e-3 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 1.709434e-3 |
GO:0015909 | long-chain fatty acid transport | 1.745891e-3 |
GO:0071169 | establishment of protein localization to chromatin | 1.773571e-3 |
GO:2000001 | regulation of DNA damage checkpoint | 1.776559e-3 |
GO:0048239 | negative regulation of DNA recombination at telomere | 1.789689e-3 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 1.789689e-3 |
GO:0032119 | sequestering of zinc ion | 1.800736e-3 |
GO:0006415 | translational termination | 1.813086e-3 |
GO:0072180 | mesonephric duct morphogenesis | 1.820337e-3 |
GO:0035601 | protein deacylation | 1.922839e-3 |
GO:0006301 | postreplication repair | 1.931095e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 1.942426e-3 |
GO:0071279 | cellular response to cobalt ion | 1.955829e-3 |
GO:0021599 | abducens nerve formation | 1.955829e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.955829e-3 |
GO:0007634 | optokinetic behavior | 1.955829e-3 |
GO:0043538 | regulation of actin phosphorylation | 2.079260e-3 |
GO:0042941 | D-alanine transport | 2.079260e-3 |
GO:0046674 | induction of retinal programmed cell death | 2.079260e-3 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 2.079260e-3 |
GO:0001777 | T cell homeostatic proliferation | 2.079260e-3 |
GO:0002352 | B cell negative selection | 2.079260e-3 |
GO:0032976 | release of matrix enzymes from mitochondria | 2.079260e-3 |
GO:0016925 | protein sumoylation | 2.142819e-3 |
GO:0001839 | neural plate morphogenesis | 2.151480e-3 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 2.151480e-3 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 2.160955e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 2.189883e-3 |
GO:0071469 | cellular response to alkalinity | 2.189883e-3 |
GO:0018345 | protein palmitoylation | 2.247083e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 2.251657e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 2.264332e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 2.282551e-3 |
GO:0043624 | cellular protein complex disassembly | 2.338312e-3 |
GO:0048793 | pronephros development | 2.349153e-3 |
GO:0032275 | luteinizing hormone secretion | 2.445696e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 2.445696e-3 |
GO:0003406 | retinal pigment epithelium development | 2.445696e-3 |
GO:0048704 | embryonic skeletal system morphogenesis | 2.501165e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 2.510483e-3 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 2.518890e-3 |
GO:0060023 | soft palate development | 2.562946e-3 |
GO:0000022 | mitotic spindle elongation | 2.592442e-3 |
GO:0030037 | actin filament reorganization involved in cell cycle | 2.638035e-3 |
GO:0016180 | snRNA processing | 2.644247e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 2.659336e-3 |
GO:0097152 | mesenchymal cell apoptosis | 2.659336e-3 |
GO:0009107 | lipoate biosynthetic process | 2.659336e-3 |
GO:0060982 | coronary artery morphogenesis | 2.659336e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.742439e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 2.772239e-3 |
GO:0000959 | mitochondrial RNA metabolic process | 2.795031e-3 |
GO:0006546 | glycine catabolic process | 2.802273e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 2.869771e-3 |
GO:0033235 | positive regulation of protein sumoylation | 2.896888e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.917686e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 2.952362e-3 |
GO:0090102 | cochlea development | 3.097091e-3 |
GO:0009069 | serine family amino acid metabolic process | 3.102856e-3 |
GO:0031167 | rRNA methylation | 3.175219e-3 |
GO:0042989 | sequestering of actin monomers | 3.259299e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 3.321510e-3 |
GO:0001710 | mesodermal cell fate commitment | 3.326942e-3 |
GO:0010159 | specification of organ position | 3.335682e-3 |
GO:0061013 | regulation of mRNA catabolic process | 3.339856e-3 |
GO:0022037 | metencephalon development | 3.377178e-3 |
GO:0021754 | facial nucleus development | 3.443700e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 3.445057e-3 |
GO:0060272 | embryonic skeletal joint morphogenesis | 3.498862e-3 |
GO:0016572 | histone phosphorylation | 3.659652e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 3.712126e-3 |
GO:0045918 | negative regulation of cytolysis | 3.713402e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 3.912426e-3 |
GO:0090402 | oncogene-induced senescence | 4.063975e-3 |
GO:0071167 | ribonucleoprotein complex import into nucleus | 4.139274e-3 |
GO:0061032 | visceral serous pericardium development | 4.164725e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 4.164725e-3 |
GO:0048210 | Golgi vesicle fusion to target membrane | 4.164725e-3 |
GO:0021993 | initiation of neural tube closure | 4.295576e-3 |
GO:0006168 | adenine salvage | 4.295576e-3 |
GO:0018916 | nitrobenzene metabolic process | 4.356192e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 4.356192e-3 |
GO:0006272 | leading strand elongation | 4.356192e-3 |
GO:0090129 | positive regulation of synapse maturation | 4.405651e-3 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 4.487654e-3 |
GO:0021610 | facial nerve morphogenesis | 4.491052e-3 |
GO:0090009 | primitive streak formation | 4.573054e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 4.573054e-3 |
GO:0072075 | metanephric mesenchyme development | 4.596130e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 4.605433e-3 |
GO:0010458 | exit from mitosis | 4.636137e-3 |
GO:0070094 | positive regulation of glucagon secretion | 4.656558e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 4.751909e-3 |
GO:0070314 | G1 to G0 transition | 4.751909e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 4.751909e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 4.759805e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 4.784087e-3 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 4.931976e-3 |
GO:0006839 | mitochondrial transport | 5.011164e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 5.083717e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 5.122371e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 5.200503e-3 |
GO:0034723 | DNA replication-dependent nucleosome organization | 5.200503e-3 |
GO:0060013 | righting reflex | 5.260030e-3 |
GO:0060969 | negative regulation of gene silencing | 5.289063e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 5.387684e-3 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 5.387913e-3 |
GO:0006281 | DNA repair | 5.486993e-3 |
GO:0090399 | replicative senescence | 5.492427e-3 |
GO:0072498 | embryonic skeletal joint development | 5.534001e-3 |
GO:0048486 | parasympathetic nervous system development | 5.638344e-3 |
GO:0051204 | protein insertion into mitochondrial membrane | 5.704822e-3 |
GO:0021561 | facial nerve development | 5.704822e-3 |
GO:0072553 | terminal button organization | 5.749903e-3 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 5.749903e-3 |
GO:0006550 | isoleucine catabolic process | 5.749903e-3 |
GO:0009098 | leucine biosynthetic process | 5.749903e-3 |
GO:0071569 | protein ufmylation | 5.794026e-3 |
GO:0007031 | peroxisome organization | 5.816845e-3 |
GO:0097119 | postsynaptic density protein 95 clustering | 5.883257e-3 |
GO:0002829 | negative regulation of type 2 immune response | 5.883257e-3 |
GO:0097104 | postsynaptic membrane assembly | 5.883257e-3 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 5.884959e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 5.968702e-3 |
GO:0097116 | gephyrin clustering | 5.976271e-3 |
GO:0021546 | rhombomere development | 5.985086e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 6.055916e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 6.055916e-3 |
GO:0001672 | regulation of chromatin assembly or disassembly | 6.062492e-3 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 6.095723e-3 |
GO:0090128 | regulation of synapse maturation | 6.232050e-3 |
GO:0001840 | neural plate development | 6.249930e-3 |
GO:0035852 | horizontal cell localization | 6.309205e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 6.309205e-3 |
GO:0035849 | nephric duct elongation | 6.309205e-3 |
GO:0035502 | metanephric ureteric bud development | 6.309205e-3 |
GO:0035847 | uterine epithelium development | 6.309205e-3 |
GO:0010734 | negative regulation of protein glutathionylation | 6.309205e-3 |
GO:0035846 | oviduct epithelium development | 6.309205e-3 |
GO:0021548 | pons development | 6.386242e-3 |
GO:0060876 | semicircular canal formation | 6.415942e-3 |
GO:0060455 | negative regulation of gastric acid secretion | 6.415942e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 6.437288e-3 |
GO:0021554 | optic nerve development | 6.466023e-3 |
GO:0042942 | D-serine transport | 6.472050e-3 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 6.472050e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 6.472050e-3 |
GO:0016575 | histone deacetylation | 6.594247e-3 |
GO:0016568 | chromatin modification | 6.968356e-3 |
GO:0009304 | tRNA transcription | 7.019470e-3 |
GO:0060033 | anatomical structure regression | 7.319803e-3 |
GO:0016567 | protein ubiquitination | 7.729443e-3 |
GO:0071545 | inositol phosphate catabolic process | 8.029910e-3 |
GO:0016576 | histone dephosphorylation | 8.067388e-3 |
GO:0006098 | pentose-phosphate shunt | 8.089548e-3 |
GO:0008054 | cyclin catabolic process | 8.217849e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.226966e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 8.297920e-3 |
GO:0043309 | regulation of eosinophil degranulation | 8.565904e-3 |
GO:0021571 | rhombomere 5 development | 8.589083e-3 |
GO:0060816 | random inactivation of X chromosome | 8.620376e-3 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 8.620376e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 8.620376e-3 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 8.620376e-3 |
GO:0032738 | positive regulation of interleukin-15 production | 8.620376e-3 |
GO:0009236 | cobalamin biosynthetic process | 8.620376e-3 |
GO:0097105 | presynaptic membrane assembly | 8.639799e-3 |
GO:0006975 | DNA damage induced protein phosphorylation | 8.639799e-3 |
GO:0065002 | intracellular protein transmembrane transport | 8.726067e-3 |
GO:0006528 | asparagine metabolic process | 8.726067e-3 |
GO:2000543 | positive regulation of gastrulation | 8.802851e-3 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 8.821197e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 8.890479e-3 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 8.926327e-3 |
GO:0090149 | membrane fission involved in mitochondrial fission | 8.926327e-3 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 8.926327e-3 |
GO:0070625 | zymogen granule exocytosis | 8.926327e-3 |
GO:0009088 | threonine biosynthetic process | 8.926327e-3 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 8.926327e-3 |
GO:0003374 | dynamin polymerization involved in mitochondrial fission | 8.926327e-3 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 9.022656e-3 |
GO:2000109 | regulation of macrophage apoptosis | 9.118745e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 9.118745e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 9.118745e-3 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 9.186297e-3 |
GO:0051168 | nuclear export | 9.232939e-3 |
GO:0015842 | synaptic vesicle amine transport | 9.274753e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 9.294604e-3 |
GO:0001881 | receptor recycling | 9.570857e-3 |
GO:0032525 | somite rostral/caudal axis specification | 9.679237e-3 |
GO:0046360 | 2-oxobutyrate biosynthetic process | 9.737436e-3 |
GO:0090234 | regulation of kinetochore assembly | 9.904530e-3 |
GO:0090169 | regulation of spindle assembly | 9.904530e-3 |
GO:0010107 | potassium ion import | 9.945369e-3 |
GO:0002121 | inter-male aggressive behavior | 9.945369e-3 |
GO:0006607 | NLS-bearing substrate import into nucleus | 1.010583e-2 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.017632e-2 |
GO:0090281 | negative regulation of calcium ion import | 1.017632e-2 |
GO:0071584 | negative regulation of zinc ion import | 1.017632e-2 |
GO:0035732 | nitric oxide storage | 1.017632e-2 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 1.017632e-2 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.017632e-2 |
GO:0072111 | cell proliferation involved in kidney development | 1.018843e-2 |
GO:0051292 | nuclear pore complex assembly | 1.037882e-2 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1.037882e-2 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 1.037882e-2 |
GO:0072164 | mesonephric tubule development | 1.039142e-2 |
GO:0045351 | type I interferon biosynthetic process | 1.039726e-2 |
GO:0019048 | virus-host interaction | 1.049703e-2 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 1.054350e-2 |
GO:0032066 | nucleolus to nucleoplasm transport | 1.065861e-2 |
GO:0048706 | embryonic skeletal system development | 1.066103e-2 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.084142e-2 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.095707e-2 |
GO:0007569 | cell aging | 1.103812e-2 |
GO:0042472 | inner ear morphogenesis | 1.119631e-2 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.124153e-2 |
GO:0045655 | regulation of monocyte differentiation | 1.126964e-2 |
GO:0071480 | cellular response to gamma radiation | 1.137030e-2 |
GO:0051865 | protein autoubiquitination | 1.140830e-2 |
GO:0006657 | CDP-choline pathway | 1.149445e-2 |
GO:0048752 | semicircular canal morphogenesis | 1.149445e-2 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 1.161692e-2 |
GO:0035329 | hippo signaling cascade | 1.162401e-2 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.165332e-2 |
GO:0031935 | regulation of chromatin silencing | 1.171060e-2 |
GO:0010837 | regulation of keratinocyte proliferation | 1.178049e-2 |
GO:0090344 | negative regulation of cell aging | 1.178558e-2 |
GO:0006273 | lagging strand elongation | 1.181732e-2 |
GO:0003062 | regulation of heart rate by chemical signal | 1.186550e-2 |
GO:0060596 | mammary placode formation | 1.224004e-2 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.243515e-2 |
GO:0046939 | nucleotide phosphorylation | 1.249966e-2 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 1.263746e-2 |
GO:0072166 | posterior mesonephric tubule development | 1.275714e-2 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.275714e-2 |
GO:0046952 | ketone body catabolic process | 1.275714e-2 |
GO:0042572 | retinol metabolic process | 1.276413e-2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.283795e-2 |
GO:0031936 | negative regulation of chromatin silencing | 1.288019e-2 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.290846e-2 |
GO:0090398 | cellular senescence | 1.300214e-2 |
GO:0007344 | pronuclear fusion | 1.302211e-2 |
GO:0018027 | peptidyl-lysine dimethylation | 1.307931e-2 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.314361e-2 |
GO:0033522 | histone H2A ubiquitination | 1.334446e-2 |
GO:0007212 | dopamine receptor signaling pathway | 1.353803e-2 |
GO:0070106 | interleukin-27-mediated signaling pathway | 1.354981e-2 |
GO:0060968 | regulation of gene silencing | 1.356246e-2 |
GO:0015919 | peroxisomal membrane transport | 1.386860e-2 |
GO:0048291 | isotype switching to IgG isotypes | 1.386860e-2 |
GO:0070370 | cellular heat acclimation | 1.386860e-2 |
GO:0031591 | wybutosine biosynthetic process | 1.386860e-2 |
GO:0002368 | B cell cytokine production | 1.386860e-2 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.386860e-2 |
GO:0006393 | termination of mitochondrial transcription | 1.386860e-2 |
GO:0033563 | dorsal/ventral axon guidance | 1.420977e-2 |
GO:0016241 | regulation of macroautophagy | 1.420977e-2 |
GO:0015862 | uridine transport | 1.420977e-2 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.422621e-2 |
GO:0007184 | SMAD protein import into nucleus | 1.435462e-2 |
GO:0016073 | snRNA metabolic process | 1.443517e-2 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 1.447313e-2 |
GO:0015908 | fatty acid transport | 1.448800e-2 |
GO:0001941 | postsynaptic membrane organization | 1.461616e-2 |
GO:0008634 | negative regulation of survival gene product expression | 1.475369e-2 |
GO:0035305 | negative regulation of dephosphorylation | 1.490813e-2 |
GO:0006783 | heme biosynthetic process | 1.493236e-2 |
GO:0070079 | histone H4-R3 demethylation | 1.534618e-2 |
GO:0070078 | histone H3-R2 demethylation | 1.534618e-2 |
GO:0014816 | satellite cell differentiation | 1.534618e-2 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.534618e-2 |
GO:0046620 | regulation of organ growth | 1.543247e-2 |
GO:0009067 | aspartate family amino acid biosynthetic process | 1.545128e-2 |
GO:0097028 | dendritic cell differentiation | 1.548401e-2 |
GO:0035284 | brain segmentation | 1.552256e-2 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.555426e-2 |
GO:0048790 | maintenance of presynaptic active zone structure | 1.593724e-2 |
GO:2000778 | positive regulation of interleukin-6 secretion | 1.593724e-2 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 1.593724e-2 |
GO:0002118 | aggressive behavior | 1.605134e-2 |
GO:0021703 | locus ceruleus development | 1.611493e-2 |
GO:0090394 | negative regulation of excitatory postsynaptic membrane potential | 1.611493e-2 |
GO:0010933 | positive regulation of macrophage tolerance induction | 1.611493e-2 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 1.615327e-2 |
GO:0032006 | regulation of TOR signaling cascade | 1.617519e-2 |
GO:0009110 | vitamin biosynthetic process | 1.623451e-2 |
GO:0070367 | negative regulation of hepatocyte differentiation | 1.623615e-2 |
GO:0043017 | positive regulation of lymphotoxin A biosynthetic process | 1.623615e-2 |
GO:0000917 | barrier septum formation | 1.623615e-2 |
GO:0009231 | riboflavin biosynthetic process | 1.623615e-2 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 1.636732e-2 |
GO:0034047 | regulation of protein phosphatase type 2A activity | 1.641253e-2 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.641253e-2 |
GO:0014912 | negative regulation of smooth muscle cell migration | 1.642963e-2 |
GO:0040015 | negative regulation of multicellular organism growth | 1.644219e-2 |
GO:0035545 | determination of left/right asymmetry in nervous system | 1.664156e-2 |
GO:0048560 | establishment of anatomical structure orientation | 1.664860e-2 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.664860e-2 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.672514e-2 |
GO:0042473 | outer ear morphogenesis | 1.672514e-2 |
GO:0002726 | positive regulation of T cell cytokine production | 1.693877e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.701409e-2 |
GO:0015879 | carnitine transport | 1.725460e-2 |
GO:0070483 | detection of hypoxia | 1.770774e-2 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 1.770774e-2 |
GO:0090239 | regulation of histone H4 acetylation | 1.772345e-2 |
GO:0021569 | rhombomere 3 development | 1.772345e-2 |
GO:0006390 | transcription from mitochondrial promoter | 1.772345e-2 |
GO:0055094 | response to lipoprotein stimulus | 1.812011e-2 |
GO:0060056 | mammary gland involution | 1.827589e-2 |
GO:0035456 | response to interferon-beta | 1.840048e-2 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.849991e-2 |
GO:0019047 | provirus integration | 1.850724e-2 |
GO:0045820 | negative regulation of glycolysis | 1.860369e-2 |
GO:0006513 | protein monoubiquitination | 1.877094e-2 |
GO:0043380 | regulation of memory T cell differentiation | 1.886582e-2 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 1.910057e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010467 | gene expression | 4.345360e-10 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.471776e-8 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 2.413778e-7 |
GO:0016070 | RNA metabolic process | 4.525302e-7 |
GO:0090304 | nucleic acid metabolic process | 5.853740e-7 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 6.778332e-7 |
GO:0061014 | positive regulation of mRNA catabolic process | 6.976561e-7 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.145160e-6 |
GO:0051930 | regulation of sensory perception of pain | 2.486238e-6 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.015661e-6 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 3.434532e-6 |
GO:0042474 | middle ear morphogenesis | 5.294499e-6 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 6.971949e-6 |
GO:0070845 | polyubiquitinated misfolded protein transport | 9.304275e-6 |
GO:0071169 | establishment of protein localization to chromatin | 1.046227e-5 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.076261e-5 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.387969e-5 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1.487842e-5 |
GO:0006352 | transcription initiation, DNA-dependent | 1.677700e-5 |
GO:0006999 | nuclear pore organization | 2.024310e-5 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 2.272696e-5 |
GO:0051973 | positive regulation of telomerase activity | 2.929753e-5 |
GO:0006396 | RNA processing | 3.400006e-5 |
GO:0048368 | lateral mesoderm development | 4.035305e-5 |
GO:0014826 | vein smooth muscle contraction | 4.456000e-5 |
GO:0051865 | protein autoubiquitination | 4.633726e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 5.384614e-5 |
GO:0065004 | protein-DNA complex assembly | 5.467220e-5 |
GO:0042254 | ribosome biogenesis | 6.128635e-5 |
GO:0097152 | mesenchymal cell apoptosis | 6.264094e-5 |
GO:0090042 | tubulin deacetylation | 6.946900e-5 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 6.946900e-5 |
GO:0070846 | Hsp90 deacetylation | 6.946900e-5 |
GO:0001759 | organ induction | 7.362142e-5 |
GO:0043488 | regulation of mRNA stability | 7.948156e-5 |
GO:0006403 | RNA localization | 8.986439e-5 |
GO:0007049 | cell cycle | 9.432832e-5 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 9.719644e-5 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 1.002950e-4 |
GO:0085020 | protein K6-linked ubiquitination | 1.002950e-4 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 1.006135e-4 |
GO:0034260 | negative regulation of GTPase activity | 1.049583e-4 |
GO:0043487 | regulation of RNA stability | 1.122041e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.165257e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.233018e-4 |
GO:0006412 | translation | 1.326071e-4 |
GO:0050685 | positive regulation of mRNA processing | 1.353833e-4 |
GO:0006351 | transcription, DNA-dependent | 1.589776e-4 |
GO:0034660 | ncRNA metabolic process | 1.650136e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.651025e-4 |
GO:0060458 | right lung development | 1.657653e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.697040e-4 |
GO:0032774 | RNA biosynthetic process | 1.846176e-4 |
GO:0035633 | maintenance of blood-brain barrier | 1.926136e-4 |
GO:0007270 | neuron-neuron synaptic transmission | 2.021408e-4 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 2.087854e-4 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 2.208776e-4 |
GO:0050658 | RNA transport | 2.478848e-4 |
GO:0044314 | protein K27-linked ubiquitination | 2.596373e-4 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 2.630917e-4 |
GO:0001881 | receptor recycling | 2.630917e-4 |
GO:0070166 | enamel mineralization | 2.736724e-4 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.771198e-4 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.771198e-4 |
GO:0032707 | negative regulation of interleukin-23 production | 2.771198e-4 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 2.771198e-4 |
GO:0060012 | synaptic transmission, glycinergic | 3.038587e-4 |
GO:0032203 | telomere formation via telomerase | 3.038587e-4 |
GO:0034661 | ncRNA catabolic process | 3.039543e-4 |
GO:0044260 | cellular macromolecule metabolic process | 3.124637e-4 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 3.141494e-4 |
GO:0060710 | chorio-allantoic fusion | 3.435332e-4 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.476575e-4 |
GO:0019363 | pyridine nucleotide biosynthetic process | 3.494710e-4 |
GO:0061304 | retinal blood vessel morphogenesis | 3.736120e-4 |
GO:0035269 | protein O-linked mannosylation | 3.861109e-4 |
GO:0009059 | macromolecule biosynthetic process | 3.941072e-4 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 4.056782e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.056782e-4 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 4.340044e-4 |
GO:0007356 | thorax and anterior abdomen determination | 4.340044e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 4.340044e-4 |
GO:0042473 | outer ear morphogenesis | 4.684311e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 4.729204e-4 |
GO:2000195 | negative regulation of female gonad development | 4.931990e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 5.283828e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 5.312900e-4 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 5.312900e-4 |
GO:0045109 | intermediate filament organization | 5.723599e-4 |
GO:0060914 | heart formation | 5.806496e-4 |
GO:0071824 | protein-DNA complex subunit organization | 5.860721e-4 |
GO:0071157 | negative regulation of cell cycle arrest | 5.911443e-4 |
GO:0060013 | righting reflex | 6.237966e-4 |
GO:2000778 | positive regulation of interleukin-6 secretion | 6.283280e-4 |
GO:0061301 | cerebellum vasculature morphogenesis | 6.283280e-4 |
GO:0035306 | positive regulation of dephosphorylation | 6.779939e-4 |
GO:0060446 | branching involved in open tracheal system development | 7.192954e-4 |
GO:0090131 | mesenchyme migration | 7.192954e-4 |
GO:2000001 | regulation of DNA damage checkpoint | 7.192954e-4 |
GO:0060461 | right lung morphogenesis | 7.192954e-4 |
GO:0014822 | detection of wounding | 7.192954e-4 |
GO:0048371 | lateral mesodermal cell differentiation | 7.192954e-4 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 7.192954e-4 |
GO:0030970 | retrograde protein transport, ER to cytosol | 7.515738e-4 |
GO:0014041 | regulation of neuron maturation | 7.660899e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.792290e-4 |
GO:0035195 | gene silencing by miRNA | 9.576040e-4 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 9.686364e-4 |
GO:0061013 | regulation of mRNA catabolic process | 9.777292e-4 |
GO:0042363 | fat-soluble vitamin catabolic process | 9.993739e-4 |
GO:0038007 | netrin-activated signaling pathway | 9.993739e-4 |
GO:0008611 | ether lipid biosynthetic process | 1.019564e-3 |
GO:0000238 | zygotene | 1.019564e-3 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 1.021274e-3 |
GO:0043687 | post-translational protein modification | 1.023512e-3 |
GO:0072355 | histone H3-T3 phosphorylation | 1.048190e-3 |
GO:0050928 | negative regulation of positive chemotaxis | 1.048190e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 1.048190e-3 |
GO:0071168 | protein localization to chromatin | 1.097200e-3 |
GO:0048143 | astrocyte activation | 1.131363e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.152779e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.159085e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.169613e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 1.182033e-3 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.182033e-3 |
GO:0007497 | posterior midgut development | 1.182033e-3 |
GO:0010312 | detoxification of zinc ion | 1.188532e-3 |
GO:0016072 | rRNA metabolic process | 1.236643e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 1.240056e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.251267e-3 |
GO:0048703 | embryonic viscerocranium morphogenesis | 1.265001e-3 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.271142e-3 |
GO:0007051 | spindle organization | 1.296042e-3 |
GO:0071498 | cellular response to fluid shear stress | 1.322607e-3 |
GO:2000194 | regulation of female gonad development | 1.358756e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.393488e-3 |
GO:0051340 | regulation of ligase activity | 1.418541e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.426150e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.426150e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.465497e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.532011e-3 |
GO:0072160 | nephron tubule epithelial cell differentiation | 1.544397e-3 |
GO:2001013 | epithelial cell proliferation involve in renal tubule morphogenesis | 1.544397e-3 |
GO:0015870 | acetylcholine transport | 1.575303e-3 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.585088e-3 |
GO:0010044 | response to aluminum ion | 1.637212e-3 |
GO:0003156 | regulation of organ formation | 1.664275e-3 |
GO:0034470 | ncRNA processing | 1.771984e-3 |
GO:0034653 | retinoic acid catabolic process | 1.809363e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 1.809363e-3 |
GO:0008380 | RNA splicing | 1.818136e-3 |
GO:0060696 | regulation of phospholipid catabolic process | 1.889158e-3 |
GO:0014002 | astrocyte development | 1.938366e-3 |
GO:0033037 | polysaccharide localization | 1.952075e-3 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 1.961616e-3 |
GO:0046755 | non-lytic virus budding | 1.973837e-3 |
GO:0015931 | nucleobase-containing compound transport | 2.030928e-3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 2.068530e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 2.091256e-3 |
GO:0090103 | cochlea morphogenesis | 2.106864e-3 |
GO:0035194 | posttranscriptional gene silencing by RNA | 2.263809e-3 |
GO:0006901 | vesicle coating | 2.318155e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 2.373180e-3 |
GO:0016071 | mRNA metabolic process | 2.375433e-3 |
GO:0014043 | negative regulation of neuron maturation | 2.467330e-3 |
GO:0050779 | RNA destabilization | 2.514454e-3 |
GO:0034720 | histone H3-K4 demethylation | 2.514454e-3 |
GO:0070625 | zymogen granule exocytosis | 2.625297e-3 |
GO:0071594 | thymocyte aggregation | 2.625297e-3 |
GO:0010933 | positive regulation of macrophage tolerance induction | 2.625297e-3 |
GO:0061298 | retina vasculature development in camera-type eye | 2.628076e-3 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.664036e-3 |
GO:0051451 | myoblast migration | 2.685479e-3 |
GO:0070830 | tight junction assembly | 2.710394e-3 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.714386e-3 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 2.720626e-3 |
GO:0048857 | neural nucleus development | 2.735065e-3 |
GO:0048680 | positive regulation of axon regeneration | 2.834251e-3 |
GO:0042659 | regulation of cell fate specification | 2.835757e-3 |
GO:0032835 | glomerulus development | 2.862742e-3 |
GO:0051583 | dopamine uptake | 2.920810e-3 |
GO:0002098 | tRNA wobble uridine modification | 2.920810e-3 |
GO:0015862 | uridine transport | 2.990197e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 3.141109e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 3.256192e-3 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 3.256192e-3 |
GO:2000297 | negative regulation of synapse maturation | 3.265764e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 3.265764e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 3.278836e-3 |
GO:0046607 | positive regulation of centrosome cycle | 3.286307e-3 |
GO:0000917 | barrier septum formation | 3.286307e-3 |
GO:0007052 | mitotic spindle organization | 3.291872e-3 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 3.298889e-3 |
GO:0006364 | rRNA processing | 3.345723e-3 |
GO:0032780 | negative regulation of ATPase activity | 3.376155e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 3.465106e-3 |
GO:0009107 | lipoate biosynthetic process | 3.511561e-3 |
GO:0060081 | membrane hyperpolarization | 3.529824e-3 |
GO:0048484 | enteric nervous system development | 3.587496e-3 |
GO:0000070 | mitotic sister chromatid segregation | 3.818416e-3 |
GO:0016032 | viral reproduction | 3.856009e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 3.869314e-3 |
GO:0003333 | amino acid transmembrane transport | 3.870922e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 3.881848e-3 |
GO:0048268 | clathrin coat assembly | 3.920227e-3 |
GO:0009108 | coenzyme biosynthetic process | 3.960195e-3 |
GO:0021571 | rhombomere 5 development | 4.007533e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 4.049429e-3 |
GO:0043587 | tongue morphogenesis | 4.067245e-3 |
GO:0006427 | histidyl-tRNA aminoacylation | 4.091836e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 4.091836e-3 |
GO:0051355 | proprioception involved in equilibrioception | 4.091836e-3 |
GO:0019047 | provirus integration | 4.091836e-3 |
GO:0042661 | regulation of mesodermal cell fate specification | 4.233016e-3 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 4.403366e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 4.524272e-3 |
GO:0045599 | negative regulation of fat cell differentiation | 4.558721e-3 |
GO:0060459 | left lung development | 4.567200e-3 |
GO:0060075 | regulation of resting membrane potential | 4.570547e-3 |
GO:2000020 | positive regulation of male gonad development | 4.581582e-3 |
GO:0000279 | M phase | 4.621187e-3 |
GO:0032728 | positive regulation of interferon-beta production | 4.637573e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 4.692072e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.844811e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 4.953854e-3 |
GO:0042660 | positive regulation of cell fate specification | 4.953854e-3 |
GO:0000076 | DNA replication checkpoint | 4.953854e-3 |
GO:0009648 | photoperiodism | 4.953854e-3 |
GO:0070170 | regulation of tooth mineralization | 5.247466e-3 |
GO:0000819 | sister chromatid segregation | 5.353538e-3 |
GO:0006900 | membrane budding | 5.387458e-3 |
GO:0034227 | tRNA thio-modification | 5.457495e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 5.457560e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 5.457560e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 5.457560e-3 |
GO:0051775 | response to redox state | 5.484299e-3 |
GO:0097029 | mature dendritic cell differentiation | 5.484299e-3 |
GO:0045919 | positive regulation of cytolysis | 5.484299e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 5.484699e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 5.552009e-3 |
GO:2000380 | regulation of mesoderm development | 5.594259e-3 |
GO:0031054 | pre-miRNA processing | 5.603379e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.645122e-3 |
GO:2000272 | negative regulation of receptor activity | 5.652886e-3 |
GO:0048255 | mRNA stabilization | 5.912772e-3 |
GO:0046452 | dihydrofolate metabolic process | 6.022269e-3 |
GO:0002418 | immune response to tumor cell | 6.022269e-3 |
GO:0030150 | protein import into mitochondrial matrix | 6.022269e-3 |
GO:0003139 | secondary heart field specification | 6.066825e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 6.074940e-3 |
GO:0051028 | mRNA transport | 6.086200e-3 |
GO:0010587 | miRNA catabolic process | 6.318689e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 6.318689e-3 |
GO:0046504 | glycerol ether biosynthetic process | 6.363835e-3 |
GO:0051145 | smooth muscle cell differentiation | 6.409176e-3 |
GO:0009649 | entrainment of circadian clock | 6.454074e-3 |
GO:0043555 | regulation of translation in response to stress | 6.527832e-3 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 6.548884e-3 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 6.646579e-3 |
GO:0016601 | Rac protein signal transduction | 6.841597e-3 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 7.003403e-3 |
GO:0000729 | DNA double-strand break processing | 7.255575e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 7.255575e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 7.255575e-3 |
GO:0006105 | succinate metabolic process | 7.337548e-3 |
GO:0035364 | thymine transport | 7.339173e-3 |
GO:0015854 | guanine transport | 7.339173e-3 |
GO:0071279 | cellular response to cobalt ion | 7.339173e-3 |
GO:0035344 | hypoxanthine transport | 7.339173e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 7.339173e-3 |
GO:0015853 | adenine transport | 7.339173e-3 |
GO:0006348 | chromatin silencing at telomere | 7.339173e-3 |
GO:0032465 | regulation of cytokinesis | 7.420232e-3 |
GO:0032530 | regulation of microvillus organization | 7.509532e-3 |
GO:0035802 | adrenal cortex formation | 7.509532e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 7.548274e-3 |
GO:0021904 | dorsal/ventral neural tube patterning | 7.571442e-3 |
GO:0021954 | central nervous system neuron development | 7.609622e-3 |
GO:0021516 | dorsal spinal cord development | 7.752255e-3 |
GO:0051795 | positive regulation of catagen | 7.806480e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 7.806480e-3 |
GO:0032497 | detection of lipopolysaccharide | 7.806480e-3 |
GO:0006268 | DNA unwinding involved in replication | 7.878468e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 7.965869e-3 |
GO:0008634 | negative regulation of survival gene product expression | 8.003072e-3 |
GO:0016925 | protein sumoylation | 8.033446e-3 |
GO:0070171 | negative regulation of tooth mineralization | 8.230403e-3 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 8.311764e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 8.514229e-3 |
GO:0044249 | cellular biosynthetic process | 8.582729e-3 |
GO:0034508 | centromere complex assembly | 8.748518e-3 |
GO:0019348 | dolichol metabolic process | 8.816521e-3 |
GO:0072193 | ureter smooth muscle cell differentiation | 9.066044e-3 |
GO:0021526 | medial motor column neuron differentiation | 9.161999e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 9.161999e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 9.161999e-3 |
GO:0046836 | glycolipid transport | 9.161999e-3 |
GO:0019428 | allantoin biosynthetic process | 9.164578e-3 |
GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 9.339395e-3 |
GO:0032288 | myelin assembly | 9.430350e-3 |
GO:0060023 | soft palate development | 9.446374e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 9.446374e-3 |
GO:0022403 | cell cycle phase | 9.476344e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 9.547822e-3 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 9.615586e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 9.651579e-3 |
GO:0048352 | paraxial mesoderm structural organization | 9.887843e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 9.887843e-3 |
GO:0021998 | neural plate mediolateral regionalization | 9.887843e-3 |
GO:0021587 | cerebellum morphogenesis | 9.968057e-3 |
GO:0048818 | positive regulation of hair follicle maturation | 1.000009e-2 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 1.009126e-2 |
GO:0002430 | complement receptor mediated signaling pathway | 1.009126e-2 |
GO:0016068 | type I hypersensitivity | 1.009126e-2 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 1.012009e-2 |
GO:0032055 | negative regulation of translation in response to stress | 1.012009e-2 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.030227e-2 |
GO:0032534 | regulation of microvillus assembly | 1.030227e-2 |
GO:0061028 | establishment of endothelial barrier | 1.047497e-2 |
GO:0046112 | nucleobase biosynthetic process | 1.100342e-2 |
GO:0007099 | centriole replication | 1.117666e-2 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.126778e-2 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 1.131996e-2 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.131996e-2 |
GO:0010889 | regulation of sequestering of triglyceride | 1.131996e-2 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.145837e-2 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.146549e-2 |
GO:0070050 | neuron homeostasis | 1.146549e-2 |
GO:0046668 | regulation of retinal cell programmed cell death | 1.149067e-2 |
GO:0042089 | cytokine biosynthetic process | 1.182139e-2 |
GO:0006397 | mRNA processing | 1.184363e-2 |
GO:0070498 | interleukin-1-mediated signaling pathway | 1.194088e-2 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.209705e-2 |
GO:0007131 | reciprocal meiotic recombination | 1.210476e-2 |
GO:0072298 | regulation of metanephric glomerulus development | 1.224015e-2 |
GO:0060711 | labyrinthine layer development | 1.258771e-2 |
GO:0072075 | metanephric mesenchyme development | 1.259448e-2 |
GO:0021559 | trigeminal nerve development | 1.279989e-2 |
GO:0031123 | RNA 3'-end processing | 1.300853e-2 |
GO:2000018 | regulation of male gonad development | 1.305195e-2 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 1.312264e-2 |
GO:0034261 | negative regulation of Ras GTPase activity | 1.312264e-2 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.338028e-2 |
GO:0072284 | metanephric S-shaped body morphogenesis | 1.338028e-2 |
GO:0035426 | extracellular matrix-cell signaling | 1.338028e-2 |
GO:0060578 | superior vena cava morphogenesis | 1.371951e-2 |
GO:0071034 | CUT catabolic process | 1.371951e-2 |
GO:0051382 | kinetochore assembly | 1.371951e-2 |
GO:0090141 | positive regulation of mitochondrial fission | 1.371951e-2 |
GO:0042373 | vitamin K metabolic process | 1.371951e-2 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 1.371951e-2 |
GO:0031508 | centromeric heterochromatin formation | 1.371951e-2 |
GO:2000987 | positive regulation of behavioral fear response | 1.373670e-2 |
GO:0060025 | regulation of synaptic activity | 1.373670e-2 |
GO:0003185 | sinoatrial valve morphogenesis | 1.373670e-2 |
GO:0035984 | cellular response to trichostatin A | 1.373670e-2 |
GO:0003138 | primary heart field specification | 1.373670e-2 |
GO:0060438 | trachea development | 1.374229e-2 |
GO:0060911 | cardiac cell fate commitment | 1.376255e-2 |
GO:0072107 | positive regulation of ureteric bud formation | 1.376467e-2 |
GO:0060020 | Bergmann glial cell differentiation | 1.378595e-2 |
GO:0043524 | negative regulation of neuron apoptosis | 1.386425e-2 |
GO:0007030 | Golgi organization | 1.406453e-2 |
GO:0001885 | endothelial cell development | 1.414411e-2 |
GO:0021527 | spinal cord association neuron differentiation | 1.414541e-2 |
GO:0061088 | regulation of sequestering of zinc ion | 1.422986e-2 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.422986e-2 |
GO:0001812 | positive regulation of type I hypersensitivity | 1.422986e-2 |
GO:0060021 | palate development | 1.436488e-2 |
GO:0045039 | protein import into mitochondrial inner membrane | 1.444240e-2 |
GO:0043297 | apical junction assembly | 1.453780e-2 |
GO:0072215 | regulation of metanephros development | 1.500866e-2 |
GO:0032490 | detection of molecule of bacterial origin | 1.522832e-2 |
GO:0018279 | protein N-linked glycosylation via asparagine | 1.522832e-2 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.527983e-2 |
GO:2000429 | negative regulation of neutrophil aggregation | 1.527983e-2 |
GO:2000469 | negative regulation of peroxidase activity | 1.527983e-2 |
GO:0071352 | cellular response to interleukin-2 | 1.527983e-2 |
GO:0042942 | D-serine transport | 1.527983e-2 |
GO:0002357 | defense response to tumor cell | 1.527983e-2 |
GO:0065002 | intracellular protein transmembrane transport | 1.527983e-2 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 1.527983e-2 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.527983e-2 |
GO:0051351 | positive regulation of ligase activity | 1.531125e-2 |
GO:0008063 | Toll signaling pathway | 1.546709e-2 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 1.546709e-2 |
GO:0007019 | microtubule depolymerization | 1.546709e-2 |
GO:0002693 | positive regulation of cellular extravasation | 1.546709e-2 |
GO:0043586 | tongue development | 1.569966e-2 |
GO:0051095 | regulation of helicase activity | 1.581851e-2 |
GO:0006538 | glutamate catabolic process | 1.581851e-2 |
GO:0048102 | autophagic cell death | 1.581851e-2 |
GO:0046580 | negative regulation of Ras protein signal transduction | 1.587296e-2 |
GO:0060729 | intestinal epithelial structure maintenance | 1.601895e-2 |
GO:0015864 | pyrimidine nucleoside transport | 1.601895e-2 |
GO:0021800 | cerebral cortex tangential migration | 1.610452e-2 |
GO:0021569 | rhombomere 3 development | 1.620920e-2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.622910e-2 |
GO:0051972 | regulation of telomerase activity | 1.655530e-2 |
GO:0051383 | kinetochore organization | 1.680006e-2 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.680006e-2 |
GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 1.689621e-2 |
GO:0050916 | sensory perception of sweet taste | 1.689621e-2 |
GO:0002232 | leukocyte chemotaxis involved in inflammatory response | 1.689621e-2 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1.689621e-2 |
GO:0072074 | kidney mesenchyme development | 1.724867e-2 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 1.733868e-2 |
GO:0014057 | positive regulation of acetylcholine secretion | 1.733868e-2 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.738297e-2 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 1.753873e-2 |
GO:0090073 | positive regulation of protein homodimerization activity | 1.768333e-2 |
GO:0006266 | DNA ligation | 1.768333e-2 |
GO:0032677 | regulation of interleukin-8 production | 1.835208e-2 |
GO:0035993 | deltoid tuberosity development | 1.838851e-2 |
GO:0009880 | embryonic pattern specification | 1.855682e-2 |
GO:0072102 | glomerulus morphogenesis | 1.865149e-2 |
GO:0043558 | regulation of translational initiation in response to stress | 1.917434e-2 |
GO:0072060 | outer medullary collecting duct development | 1.917434e-2 |
GO:0072061 | inner medullary collecting duct development | 1.917434e-2 |
GO:0021644 | vagus nerve morphogenesis | 1.917434e-2 |
GO:0019230 | proprioception | 1.917434e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.917434e-2 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.926112e-2 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1.956132e-2 |
GO:0090140 | regulation of mitochondrial fission | 1.972821e-2 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 1.972821e-2 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.972821e-2 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 1.976740e-2 |
GO:0061056 | sclerotome development | 1.982650e-2 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 1.982650e-2 |
GO:0031573 | intra-S DNA damage checkpoint | 1.982650e-2 |
GO:0060017 | parathyroid gland development | 1.990151e-2 |
GO:0042471 | ear morphogenesis | 1.993611e-2 |
GO:0051301 | cell division | 2.013004e-2 |
GO:0033081 | regulation of T cell differentiation in thymus | 2.016023e-2 |
GO:0010453 | regulation of cell fate commitment | 2.036403e-2 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.063580e-2 |
GO:0010468 | regulation of gene expression | 2.064821e-2 |
GO:0050847 | progesterone receptor signaling pathway | 2.091642e-2 |
GO:0072166 | posterior mesonephric tubule development | 2.094546e-2 |
GO:0046340 | diacylglycerol catabolic process | 2.094546e-2 |
GO:0032508 | DNA duplex unwinding | 2.101526e-2 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.126679e-2 |
GO:0046874 | quinolinate metabolic process | 2.157315e-2 |
GO:0007043 | cell-cell junction assembly | 2.197525e-2 |
GO:0033083 | regulation of immature T cell proliferation | 2.210535e-2 |
GO:0046931 | pore complex assembly | 2.222047e-2 |
GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.222047e-2 |
GO:0043583 | ear development | 2.235513e-2 |
GO:0070076 | histone lysine demethylation | 2.247945e-2 |
GO:0032202 | telomere assembly | 2.293579e-2 |
GO:0051292 | nuclear pore complex assembly | 2.293579e-2 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 2.293579e-2 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 2.295903e-2 |
GO:0090245 | axis elongation involved in somitogenesis | 2.295903e-2 |
GO:0021570 | rhombomere 4 development | 2.295903e-2 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 2.295903e-2 |
GO:0000492 | box C/D snoRNP assembly | 2.295903e-2 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 2.322287e-2 |
GO:0042147 | retrograde transport, endosome to Golgi | 2.323992e-2 |
GO:2000108 | positive regulation of leukocyte apoptosis | 2.349085e-2 |
GO:0007619 | courtship behavior | 2.374616e-2 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 2.374616e-2 |
GO:0021884 | forebrain neuron development | 2.379457e-2 |
GO:0006415 | translational termination | 2.393886e-2 |
GO:0007076 | mitotic chromosome condensation | 2.425642e-2 |
GO:0016486 | peptide hormone processing | 2.485019e-2 |
GO:0048562 | embryonic organ morphogenesis | 2.493018e-2 |
GO:0072164 | mesonephric tubule development | 2.504636e-2 |
GO:0042941 | D-alanine transport | 2.507824e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 2.507824e-2 |
GO:0060033 | anatomical structure regression | 2.510824e-2 |
GO:0017145 | stem cell division | 2.547376e-2 |
GO:0006405 | RNA export from nucleus | 2.618547e-2 |
GO:0050823 | peptide antigen stabilization | 2.629511e-2 |
GO:0071786 | endoplasmic reticulum tubular network organization | 2.629511e-2 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 2.629511e-2 |
GO:0032342 | aldosterone biosynthetic process | 2.629511e-2 |
GO:0002537 | nitric oxide production involved in inflammatory response | 2.629511e-2 |
GO:0032057 | negative regulation of translational initiation in response to stress | 2.629511e-2 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.629511e-2 |
GO:0014033 | neural crest cell differentiation | 2.634964e-2 |
GO:0045616 | regulation of keratinocyte differentiation | 2.651889e-2 |
GO:0006334 | nucleosome assembly | 2.674185e-2 |
GO:0021508 | floor plate formation | 2.739341e-2 |
GO:0006540 | glutamate decarboxylation to succinate | 2.739341e-2 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.739341e-2 |
GO:0050931 | pigment cell differentiation | 2.748920e-2 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 2.760713e-2 |
GO:0032392 | DNA geometric change | 2.786508e-2 |
GO:0010224 | response to UV-B | 2.831589e-2 |
GO:0015920 | lipopolysaccharide transport | 2.863517e-2 |
GO:0010661 | positive regulation of muscle cell apoptosis | 2.878413e-2 |
GO:0032446 | protein modification by small protein conjugation | 2.880592e-2 |
GO:0007288 | sperm axoneme assembly | 2.886148e-2 |
GO:0007032 | endosome organization | 2.888525e-2 |
GO:0022402 | cell cycle process | 2.889733e-2 |
GO:0035249 | synaptic transmission, glutamatergic | 2.895224e-2 |
GO:0010870 | positive regulation of receptor biosynthetic process | 2.895282e-2 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 2.895282e-2 |